Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CMW Laboratories is a specialized medical device company primarily known for its development and manufacture of bone cements used in orthopedic surgery. Based in the United Kingdom, the company became a global leader in polymethyl methacrylate (PMMA) technology, providing essential materials for anchoring prosthetic joints. Its product portfolio includes well-known brands such as CMW 1, CMW 2, and CMW 3 bone cements, which offer varying viscosities to suit different surgical requirements. The company was acquired by DePuy in 1994, which subsequently became part of Johnson & Johnson's DePuy Synthes division. CMW's technologies continue to be a cornerstone of the orthopedic cement market, supported by advanced mixing and delivery systems like the SmartMix platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CMW Laboratories.